|
市場調査レポート
商品コード
1762332
外用薬CDMO市場、規模、シェア、動向、産業分析レポート：製剤別、サービス別、最終用途別、地域別、2025年～2034年の市場予測Topical Drugs CDMO Market Size, Share, Trends, & Industry Analysis Report By Formulation (Semi-Solid Formulations, Liquid Formulations, Solid Formulations, and Transdermal Products), Service, End Use, By Region - Market Forecast, 2025-2034 |
||||||
カスタマイズ可能
|
|||||||
価格
| 外用薬CDMO市場、規模、シェア、動向、産業分析レポート：製剤別、サービス別、最終用途別、地域別、2025年～2034年の市場予測 |
|
出版日: 2025年06月01日
発行: Polaris Market Research
ページ情報: 英文 130 Pages
納期: 即日から翌営業日
|
- 全表示
- 概要
- 図表
- 目次
概要
Polaris Market Research社の最新調査によると、外用薬CDMO市場の世界市場規模は2034年までに1,254億2,000万米ドルに達する見込みです。本レポートでは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。
外用薬CDMO市場とは、皮膚や粘膜に直接塗布するように設計された医薬品の開発、製剤化、生産のための包括的なサービスを提供する専門企業を指します。これらのサービスは、初期の研究開発から商業製品の大規模製造まで、外用薬のライフサイクル全体にわたっています。基本的に、CDMOは製薬会社やバイオ製薬会社にとって重要なパートナーとして機能し、さまざまな外用薬を効率的に、厳しい規制基準に準拠して市場に送り出す手助けをします。
湿疹、乾癬、にきびなど様々な皮膚疾患の世界の蔓延の増加は、革新的な外用治療への需要を煽る。このため、製薬企業は、粘膜薬を含む複雑な外用薬の製剤化・製造に関する専門知識を持つCDMOに依存するようになっています。さらに、製薬業界におけるアウトソーシングの動向の高まりは、コスト効率と柔軟な製造能力の必要性によって後押しされ、外用薬CDMOサービスの需要をさらに押し上げています。
外用薬CDMO市場レポートハイライト
製剤別では、皮膚科、疼痛管理、抗感染症薬などさまざまな治療領域で広く使用されていることから、半固形製剤分野が2024年に最大のシェアを占めました。
サービス別では、受託製造部門が2024年に市場を席巻しました。製薬企業が専門知識の活用、運用コストの削減、拡張可能な製造能力のメリットを得るために、外用薬の実際の製造を外注するケースが増えているためです。
最終用途別では、製薬企業が一般用医薬品から医療用医薬品まで幅広い外用薬のポートフォリオを一貫して開発・商品化していることから、2024年には製薬企業セグメントが最大のシェアを占めました。
地域別では、アジア太平洋地域が2024年の外用薬CDMO市場で最大のシェアを占めました。これは主に、製造における費用対効果、医療インフラの拡大、中国やインドなどの国々における製薬産業の成長が、外用薬製造の世界のアウトソーシングの魅力的な拠点となっていることに起因しています。
同市場の主要企業には、The Lubrizol Corporation（Lubrizol Life Science）、Cambrex Corporation、Lonza Group AG、Catalent Inc.、Recipharm AB、Pierre Fabre S.A.、Piramal Pharma Solutions、PCI Pharma Services、MedPharm Ltd.、Tergus Pharma、Contract Pharmaceuticals Limitedなどがあります。
目次
第1章 イントロダクション
第2章 エグゼクティブサマリー
第3章 調査手法
第4章 世界の外用薬CDMO市場の洞察
- 市場スナップショット
- 外用薬CDMO市場力学
- 促進要因と機会
- 皮膚疾患の増加
- 医薬品アウトソーシングの成長傾向
- 抑制要因と課題
- 規制の複雑さと厳格さ
- 促進要因と機会
- PESTEL分析
- 外用薬CDMO市場のアプリケーション動向
- バリューチェーン分析
- COVID-19の影響分析
第5章 世界の外用薬CDMO市場：製剤別
- 主な調査結果
- イントロダクション
- 半固形製剤
- 液体製剤
- 固形製剤
- 経皮吸収型製品
第6章 世界の外用薬CDMO市場：サービス別
- 主な調査結果
- イントロダクション
- 契約開発
- 契約製造
第7章 世界の外用薬CDMO市場：最終用途別
- 主な調査結果
- イントロダクション
- 製薬会社
- バイオ医薬品企業
- その他
第8章 世界の外用薬CDMO市場：地域別
- 主な調査結果
- イントロダクション
- 外用薬CDMO市場分析：地域別、2020年～2034年
- 北米
- 北米：製剤別、2020～2034年
- 北米：サービス別、2020～2034年
- 北米：最終用途別、2020～2034年
- 米国
- カナダ
- 欧州
- 欧州：製剤別、2020～2034年
- 欧州：サービス別、2020～2034年
- 欧州：最終用途別、2020～2034年
- 英国
- フランス
- ドイツ
- イタリア
- スペイン
- オランダ
- ロシア
- その他欧州
- アジア太平洋
- アジア太平洋地域：製剤別、2020～2034年
- アジア太平洋地域：サービス別、2020～2034年
- アジア太平洋地域：最終用途別、2020～2034年
- 中国
- インド
- マレーシア
- 日本
- インドネシア
- 韓国
- オーストラリア
- その他アジア太平洋地域
- 中東・アフリカ
- 中東・アフリカ：製剤別、2020～2034年
- 中東・アフリカ：サービス別、2020～2034年
- 中東・アフリカ：最終用途別、2020～2034年
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- 南アフリカ
- その他中東とアフリカ
- ラテンアメリカ
- ラテンアメリカ：製剤別、2020～2034年
- ラテンアメリカ：サービス別、2020～2034年
- ラテンアメリカ：最終用途別、2020～2034年
- メキシコ
- ブラジル
- アルゼンチン
- その他ラテンアメリカ
第9章 競合情勢
- 拡大と買収の分析
- 拡大
- 買収
- 提携/協業/合意/公開
第10章 企業プロファイル
- Cambrex Corporation
- Catalent Inc.
- Contract Pharmaceuticals Limited
- MedPharm Ltd.
- PCI Pharma Services
- Pierre Fabre S.A.
- Piramal Pharma Solutions
- Recipharm AB
- Tergus Pharma
- The Lubrizol Corporation（Lubrizol Life Science）
図表
List of Tables:
- Table 1 Global Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- Table 2 Global Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- Table 3 Global Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- Table 4 North America: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- Table 5 North America: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- Table 6 North America: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- Table 7 U.S.: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- Table 8 U.S.: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- Table 9 U.S.: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- Table 10 Canada: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- Table 11 Canada: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- Table 12 Canada: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- Table 13 Europe: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- Table 14 Europe: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- Table 15 Europe: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- Table 16 UK: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- Table 17 UK: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- Table 18 UK: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- Table 19 France: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- Table 20 France: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- Table 21 France: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- Table 22 Germany: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- Table 23 Germany: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- Table 24 Germany: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- Table 25 Italy: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- Table 26 Italy: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- Table 27 Italy: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- Table 28 Spain: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- Table 29 Spain: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- Table 30 Spain: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- Table 31 Netherlands: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- Table 32 Netherlands: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- Table 33 Netherlands: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- Table 34 Russia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- Table 35 Russia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- Table 36 Russia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- Table 37 Rest of Europe: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- Table 38 Rest of Europe: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- Table 39 Rest of Europe: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- Table 40 Asia Pacific: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- Table 41 Asia Pacific: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- Table 42 Asia Pacific: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- Table 43 China: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- Table 44 China: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- Table 45 China: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- Table 46 India: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- Table 47 India: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- Table 48 India: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- Table 49 Malaysia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- Table 50 Malaysia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- Table 51 Malaysia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- Table 52 Japan: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- Table 53 Japan: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- Table 54 Japan: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- Table 55 Indonesia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- Table 56 Indonesia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- Table 57 Indonesia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- Table 58 South Korea: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- Table 59 South Korea: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- Table 60 South Korea: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- Table 61 Australia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- Table 62 Australia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- Table 63 Australia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- Table 64 Rest of Asia Pacific: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- Table 65 Rest of Asia Pacific: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- Table 66 Rest of Asia Pacific: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- Table 67 Middle East & Africa: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- Table 68 Middle East & Africa: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- Table 69 Middle East & Africa: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- Table 70 Saudi Arabia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- Table 71 Saudi Arabia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- Table 72 Saudi Arabia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- Table 73 UAE: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- Table 74 UAE: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- Table 75 UAE: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- Table 76 Israel: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- Table 77 Israel: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- Table 78 Israel: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- Table 79 South Africa: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- Table 80 South Africa: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- Table 81 South Africa: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- Table 82 Rest of Middle East & Africa: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- Table 83 Rest of Middle East & Africa: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- Table 84 Rest of Middle East & Africa: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- Table 85 Latin America: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- Table 86 Latin America: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- Table 87 Latin America: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- Table 88 Mexico: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- Table 89 Mexico: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- Table 90 Mexico: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- Table 91 Brazil: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- Table 92 Brazil: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- Table 93 Brazil: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- Table 94 Argentina: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- Table 95 Argentina: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- Table 96 Argentina: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- Table 97 Rest of Latin America: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- Table 98 Rest of Latin America: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- Table 99 Rest of Latin America: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
List of Figures:
- Figure 1. Global Topical Drugs CDMO Market, 2020-2034 (USD Billion)
- Figure 2. Integrated Ecosystem
- Figure 3. Research Methodology: Top-Down & Bottom-Up Price
- Figure 4. Market by Geography
- Figure 5. Porter's Five Forces
- Figure 6. Market by Formulation
- Figure 7. Global Topical Drugs CDMO Market, by Formulation, 2024 & 2034 (USD Billion)
- Figure 8. Market by Service
- Figure 9. Global Topical Drugs CDMO Market, by Service, 2024 & 2034 (USD Billion)
- Figure 10. Market by End Use
- Figure 11. Global Topical Drugs CDMO Market, by End Use, 2024 & 2034 (USD Billion)
目次
Product Code: PM5815
The topical drugs cdmo market global market size is expected to reach USD 125.42 billion by 2034, according to a new study by Polaris Market Research. The report "Topical Drugs CDMO Market Size, Share, Trends, & Industry Analysis Report By Formulation (Semi-solid Formulations, Liquid Formulations, Solid Formulations, and Transdermal Products), By Service, By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The topical drugs CDMO market refers to specialized companies that provide comprehensive services for the development, formulation, and production of pharmaceutical products designed to be applied directly to the skin or mucous membranes. These services span the entire lifecycle of a topical drug, from initial research and development to the large-scale manufacturing of commercial products. Essentially, CDMOs act as crucial partners for pharmaceutical and biopharmaceutical companies, helping them bring a wide array of topical medications to market efficiently and in compliance with strict regulatory standards.
The increasing global prevalence of various skin conditions, such as eczema, psoriasis, and acne, fuels the demand for innovative topical treatments. This, in turn, leads pharmaceutical companies to rely on CDMOs for their specialized expertise in formulating and producing complex topical medications, including mucosal drugs. Additionally, the growing trend of outsourcing within the pharmaceutical industry, driven by cost-efficiency and the need for flexible manufacturing capabilities, further boosts the demand for topical drugs CDMO services.
Topical Drugs CDMO Market Report Highlights
By formulation, the semi-solid formulations segment held the largest share in 2024 due to their widespread use across various therapeutic areas such as dermatology, pain management, and anti-infectives.
Based on service, the contract manufacturing segment dominated the market in 2024, as pharmaceutical companies increasingly outsource the actual production of their topical drugs to leverage specialized expertise, reduce operational costs, and benefit from scalable manufacturing capabilities.
By end use, the pharmaceutical companies segment held the largest share in 2024 as they consistently develop and commercialize a broad portfolio of topical drugs, from over-the-counter to prescription medications.
By region, Asia Pacific held the largest share of the topical drugs CDMO market in 2024. This is primarily attributed to cost-effectiveness in manufacturing, expanding healthcare infrastructure, and growing pharmaceutical industries in countries such as China and India, making it an attractive hub for global outsourcing of topical drug production.
A few key players in the market include The Lubrizol Corporation (Lubrizol Life Science), Cambrex Corporation, Lonza Group AG, Catalent Inc., Recipharm AB, Pierre Fabre S.A., Piramal Pharma Solutions, PCI Pharma Services, MedPharm Ltd., Tergus Pharma, and Contract Pharmaceuticals Limited.
Polaris Market Research has segmented the topical drugs CDMO market report based on formulation, service, end use, and region:
By Formulation Outlook (Revenue - USD Billion, 2020-2034)
Semi-solid Formulations
Creams
Ointments
Gel
Others
Liquid Formulations
Solid Formulations
Transdermal Products
By Service Outlook (Revenue - USD Billion, 2020-2034)
Contract Development
Contract Manufacturing
By End Use Outlook (Revenue - USD Billion, 2020-2034)
Pharmaceutical Companies
Biopharmaceutical Companies
Others
By Regional Outlook (Revenue - USD Billion, 2020-2034)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source
4. Global Topical Drugs CDMO Market Insights
- 4.1. Topical Drugs CDMO Market - Market Snapshot
- 4.2. Topical Drugs CDMO Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing Prevalence of Skin Conditions
- 4.2.1.2. Growing Trend of Pharmaceutical Outsourcing
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Regulatory Complexity and Stringency
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Topical Drugs CDMO Market Application Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Topical Drugs CDMO Market, by Formulation
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 5.3. Semi-solid Formulations
- 5.3.1. Global Topical Drugs CDMO Market, by Semi-solid Formulations, by Region, 2020-2034 (USD Billion)
- 5.4. Liquid Formulations
- 5.4.1. Global Topical Drugs CDMO Market, by Liquid Formulations, by Region, 2020-2034 (USD Billion)
- 5.5. Solid Formulations
- 5.5.1. Global Topical Drugs CDMO Market, by Solid Formulations, by Region, 2020-2034 (USD Billion)
- 5.6. Transdermal Products
- 5.6.1. Global Topical Drugs CDMO Market, by Transdermal Products, by Region, 2020-2034 (USD Billion)
6. Global Topical Drugs CDMO Market, by Service
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 6.3. Contract Development
- 6.3.1. Global Topical Drugs CDMO Market, by Contract Development, by Region, 2020-2034 (USD Billion)
- 6.4. Contract Manufacturing
- 6.4.1. Global Topical Drugs CDMO Market, by Contract Manufacturing, by Region, 2020-2034 (USD Billion)
7. Global Topical Drugs CDMO Market, by End Use
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 7.3. Pharmaceutical Companies
- 7.3.1. Global Topical Drugs CDMO Market, by Pharmaceutical Companies, by Region, 2020-2034 (USD Billion)
- 7.4. Biopharmaceutical Companies
- 7.4.1. Global Topical Drugs CDMO Market, by Biopharmaceutical Companies, by Region, 2020-2034 (USD Billion)
- 7.5. Others
- 7.5.1. Global Topical Drugs CDMO Market, by Others, by Region, 2020-2034 (USD Billion)
8. Global Topical Drugs CDMO Market, by Geography
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Topical Drugs CDMO Market Assessment, By Geography, 2020-2034 (USD Billion)
- 8.3. Topical Drugs CDMO Market - North America
- 8.3.1. North America: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.3.2. North America: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.3.3. North America: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.3.4. Topical Drugs CDMO Market - U.S.
- 8.3.4.1. U.S.: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.3.4.2. U.S.: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.3.4.3. U.S.: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.3.5. Topical Drugs CDMO Market - Canada
- 8.3.5.1. Canada: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.3.5.2. Canada: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.3.5.3. Canada: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.4. Topical Drugs CDMO Market - Europe
- 8.4.1. Europe: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.4.2. Europe: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.4.3. Europe: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.4.4. Topical Drugs CDMO Market - UK
- 8.4.4.1. UK: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.4.4.2. UK: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.4.4.3. UK: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.4.5. Topical Drugs CDMO Market - France
- 8.4.5.1. France: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.4.5.2. France: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.4.5.3. France: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.4.6. Topical Drugs CDMO Market - Germany
- 8.4.6.1. Germany: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.4.6.2. Germany: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.4.6.3. Germany: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.4.7. Topical Drugs CDMO Market - Italy
- 8.4.7.1. Italy: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.4.7.2. Italy: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.4.7.3. Italy: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.4.8. Topical Drugs CDMO Market - Spain
- 8.4.8.1. Spain: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.4.8.2. Spain: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.4.8.3. Spain: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.4.9. Topical Drugs CDMO Market - Netherlands
- 8.4.9.1. Netherlands: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.4.9.2. Netherlands: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.4.9.3. Netherlands: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.4.10. Topical Drugs CDMO Market - Russia
- 8.4.10.1. Russia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.4.10.2. Russia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.4.10.3. Russia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.4.11. Topical Drugs CDMO Market - Rest of Europe
- 8.4.11.1. Rest of Europe: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.4.11.2. Rest of Europe: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.4.11.3. Rest of Europe: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.5. Topical Drugs CDMO Market - Asia Pacific
- 8.5.1. Asia Pacific: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.5.4. Topical Drugs CDMO Market - China
- 8.5.4.1. China: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.5.4.2. China: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.5.4.3. China: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.5.5. Topical Drugs CDMO Market - India
- 8.5.5.1. India: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.5.5.2. India: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.5.5.3. India: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.5.6. Topical Drugs CDMO Market - Malaysia
- 8.5.6.1. Malaysia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.5.6.2. Malaysia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.5.6.3. Malaysia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.5.7. Topical Drugs CDMO Market - Japan
- 8.5.7.1. Japan: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.5.7.2. Japan: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.5.7.3. Japan: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.5.8. Topical Drugs CDMO Market - Indonesia
- 8.5.8.1. Indonesia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.5.8.2. Indonesia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.5.8.3. Indonesia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.5.9. Topical Drugs CDMO Market - South Korea
- 8.5.9.1. South Korea: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.5.9.2. South Korea: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.5.9.3. South Korea: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.5.10. Topical Drugs CDMO Market - Australia
- 8.5.10.1. Australia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.5.10.2. Australia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.5.10.3. Australia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.5.11. Topical Drugs CDMO Market - Rest of Asia Pacific
- 8.5.11.1. Rest of Asia Pacific: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.5.11.2. Rest of Asia Pacific: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.5.11.3. Rest of Asia Pacific: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.6. Topical Drugs CDMO Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.6.4. Topical Drugs CDMO Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.6.4.2. Saudi Arabia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.6.4.3. Saudi Arabia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.6.5. Topical Drugs CDMO Market - UAE
- 8.6.5.1. UAE: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.6.5.2. UAE: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.6.5.3. UAE: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.6.6. Topical Drugs CDMO Market - Israel
- 8.6.6.1. Israel: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.6.6.2. Israel: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.6.6.3. Israel: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.6.7. Topical Drugs CDMO Market - South Africa
- 8.6.7.1. South Africa: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.6.7.2. South Africa: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.6.7.3. South Africa: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.6.8. Topical Drugs CDMO Market - Rest of Middle East & Africa
- 8.6.8.1. Rest of Middle East & Africa: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.6.8.2. Rest of Middle East & Africa: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.6.8.3. Rest of Middle East & Africa: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.7. Topical Drugs CDMO Market - Latin America
- 8.7.1. Latin America: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.7.4. Topical Drugs CDMO Market - Mexico
- 8.7.4.1. Mexico: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.7.4.2. Mexico: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.7.4.3. Mexico: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.7.5. Topical Drugs CDMO Market - Brazil
- 8.7.5.1. Brazil: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.7.5.2. Brazil: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.7.5.3. Brazil: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.7.6. Topical Drugs CDMO Market - Argentina
- 8.7.6.1. Argentina: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.7.6.2. Argentina: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.7.6.3. Argentina: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
- 8.7.7. Topical Drugs CDMO Market - Rest of Latin America
- 8.7.7.1. Rest of Latin America: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
- 8.7.7.2. Rest of Latin America: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
- 8.7.7.3. Rest of Latin America: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Cambrex Corporation
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Catalent Inc.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Contract Pharmaceuticals Limited
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. MedPharm Ltd.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. PCI Pharma Services
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Pierre Fabre S.A.
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Piramal Pharma Solutions
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Recipharm AB
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Tergus Pharma
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. The Lubrizol Corporation (Lubrizol Life Science)
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
